A detailed history of Coppell Advisory Solutions Corp. transactions in Amgen Inc stock. As of the latest transaction made, Coppell Advisory Solutions Corp. holds 7,371 shares of AMGN stock, worth $2.29 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
7,371
Previous 4,865 51.51%
Holding current value
$2.29 Million
Previous $1.17 Billion 78.6%
% of portfolio
0.4%
Previous 0.38%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $673,788 - $813,347
2,506 Added 51.51%
7,371 $2.1 Billion
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $134,796 - $164,294
597 Added 13.99%
4,865 $1.17 Billion
Q4 2022

Feb 17, 2023

BUY
$229.03 - $291.01 $977,500 - $1.24 Million
4,268 New
4,268 $1.12 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Coppell Advisory Solutions Corp. Portfolio

Follow Coppell Advisory Solutions Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions Corp., based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions Corp. with notifications on news.